OTA2017: Ketotifen fumarate for reducing joint contracture after distal humerus/proximal radial Frx
OTA2017: Ketotifen fumarate for reducing joint contracture after distal humerus/proximal radial Frx
Randomized, Placebo-Controlled Clinical Trial Evaluating Ketotifen Fumarate in Reduction of Posttraumatic Elbow Joint Contracture
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
145 patients with either a fracture of either the distal humerus or proximal radius were randomized to 6-week therapy with either ketotifen fumarate or placebo. The purpose of this phase II, feasibility study was to examine any possible effect of ketotifen fumarate on elbow joint range of motion at 12 weeks post-injury, as well as to collect data for subsequent studies. Patients were managed with ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.